We show that the differentiation blockage of E2A-PBX1-expressing precursor B-ALL cells can be abolished in vitro by the pharmacological activation of PKC, and that the differentiation of these cells is accompanied by marked changes in SERCA expression. The gene discussed is PRRT2; the disease is precursor B-cell acute lymphoblastic leukemia.